PureHealth Holding Pjsc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: AEE01362P238
AED
2.11
0.02 (0.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
7,262.33
7,210.81
6,527.17
6,993.03
6,580.95
6,892.34
6,452.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
7,262.33
7,210.81
6,527.17
6,993.03
6,580.95
6,892.34
6,452.27
Raw Material Cost
5,583.97
5,599.65
4,713.63
5,432.88
4,833.08
5,183.48
4,415.75
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
234.59
287.40
184.92
178.56
213.97
242.93
218.33
Selling and Distribution Expenses
1,259.71
1,239.69
1,355.25
980.49
1,156.36
1,620.31
1,377.48
Other Expenses
-23.46
-28.74
-18.49
-17.86
-21.40
-24.29
-21.83
Total Expenditure (Excl Depreciation)
6,843.68
6,839.34
6,068.88
6,413.37
5,989.44
6,803.79
5,793.23
Operating Profit (PBDIT) excl Other Income
418.7
371.5
458.29999999999995
579.7
591.5
88.5
659
Other Income
266.48
-491.60
289.92
206.86
178.62
-68.70
4.64
Operating Profit (PBDIT)
1,183.66
457.44
1,168.56
1,202.15
1,164.80
488.08
974.72
Interest
234.59
287.40
184.92
178.56
213.97
242.93
218.33
Exceptional Items
0.00
0.80
0.00
0.00
0.00
87.43
0.00
Gross Profit (PBDT)
1,678.36
1,611.16
1,813.54
1,560.15
1,747.87
1,708.86
2,036.52
Depreciation
498.53
577.57
420.35
415.63
394.66
468.23
311.05
Profit Before Tax
450.54
494.50
563.30
607.96
556.16
260.86
445.34
Tax
42.19
28.43
47.72
90.23
55.63
-29.59
40.23
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
386.56
455.16
520.82
522.28
503.85
278.50
430.55
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
386.56
455.16
520.82
522.28
503.85
278.50
430.55
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
28.30
14.54
0.76
1.31
1.38
0.88
1.45
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
414.86
469.70
521.58
523.60
505.23
279.38
432.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
18,496.61
18,301.30
20,854.42
20,452.25
19,994.34
19,714.19
19,287.72
Earnings per share (EPS)
0.03
0.04
0.05
0.05
0.05
0.03
0.04
Diluted Earnings per share
0.03
0.04
0.05
0.05
0.05
0.03
0.04
Operating Profit Margin (Excl OI)
5.76%
5.15%
7.02%
8.29%
8.99%
1.28%
10.21%
Gross Profit Margin
13.07%
14.87%
15.07%
14.64%
14.45%
10.58%
11.72%
PAT Margin
5.32%
6.31%
7.98%
7.47%
7.66%
4.04%
6.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 10.35% vs 7.62% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -17.87% vs 2.98% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -7.00% vs 2.74% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 9.63% vs 8.74% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of PureHealth Holding Pjsc With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(AED)
Change(%)
Net Sales
7,262.33
0
7,262.33
Other Operating Income
0.00
0.00
0.00
Total Operating income
7,262.33
0
7,262.33
Raw Material Cost
5,583.97
0
5,583.97
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
234.59
0
234.59
Selling and Distribution Expenses
1,259.71
0
1,259.71
Other Expenses
-23.46
0.00
-23.46
Total Expenditure (Excl Depreciation)
6,843.68
0
6,843.68
Operating Profit (PBDIT) excl Other Income
418.65
0.00
418.65
Other Income
266.48
0
266.48
Operating Profit (PBDIT)
1,183.66
0
1,183.66
Interest
234.59
0
234.59
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,678.36
0
1,678.36
Depreciation
498.53
0
498.53
Profit Before Tax
450.54
0
450.54
Tax
42.19
0
42.19
Provisions and contingencies
0
0
0.00
Profit After Tax
386.56
0
386.56
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
386.56
0
386.56
Share in Profit of Associates
0
0
0.00
Minority Interest
28.30
0
28.30
Other related items
0.00
0.00
0.00
Consolidated Net Profit
414.86
0
414.86
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
18,496.61
0
18,496.61
Earnings per share (EPS)
0.03
0
0.03
Diluted Earnings per share
0.03
0
0.03
Operating Profit Margin (Excl OI)
5.76%
0%
0.00
5.76%
Gross Profit Margin
13.07%
0%
0.00
13.07%
PAT Margin
5.32%
0%
0.00
5.32%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 726.23 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.71% vs 10.47% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 10.35% vs 7.62% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 41.49 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -11.67% vs -9.95% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -17.87% vs 2.98% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.72 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -3.35% vs 8.01% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -7.00% vs 2.74% in Mar 2025

Quarterly - Interest
Interest 23.46 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -18.37% vs 55.44% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 9.63% vs 8.74% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.76%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025